| 
Results for adalimumab. Search took 0.01 seconds.
Abbott's HUMIRA(R) (adalimumab) FDA-Approved For Moderate to Severe Chronic Plaque Psoriasis
in Straightfromthedoc, on January 21, 2008
...The US FDA has recently approved the marketing of Abbott' s HUMIRA(R) (adalimumab) as a treatment for adult patients with moderate to severe chronic plaque psoriasis .
Plaque psoriasi...
EU Approves Humira® Drug Against Ankylosing Spondylitis
in The Biotech Weblog, on June 8, 2006
... EU regulatory bodies granted approval to market Humira® (adalimumab) in Europe. Humira is an arthritis drug from Abbott , indicated for severe, active ankylosing spondylitis (AS) .
Ankylosin...